1. Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas

   • Davut Pehlivan
   • Esra Gunduz
   • Kenji Shimizu

   Original Paper 03 June 2008 Pages: 1267 - 1276

   

2. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007

   • Jeong-Yeol Park
   • Dae-Yeon Kim
   • Joo-Hyun Nam

   Original Paper 28 May 2008 Pages: 1277 - 1287

   

3. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer

   • Kai Ma
   • Dong Chang
   • Tianyou Wang

   Original Paper 27 May 2008 Pages: 1289 - 1295

   

4. Differences in presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience

   • Dionisios Mitropoulos
   • Andreas Petrolekas
   • Anastasios Zervas

   Original Paper 27 May 2008 Pages: 1297 - 1301

   

5. Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease

   • Kyriaki Mystakidou
   • Evangelia Stathopoulou
   • Lambros Vlahos

   Original Paper 27 May 2008 Pages: 1303 - 1310

   

6. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study

   • Volker Arndt
   • Christa Stegmaier
   • Hermann Brenner

   Original Paper 27 May 2008 Pages: 1311 - 1318

   

7. Clinical identification of colorectal cancer patients benefiting from adjuvant uracil–tegafur (UFT): a randomized controlled trial

   • Masashi Fujii
   • Tadatoshi Takayama
   • Mitsugu Kochi

   Original Paper Open access 30 May 2008 Pages: 1319 - 1323

   

8. A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

   • Kimberly B. Higginbotham
   • Richard Lozano
   • Melanie B. Thomas

   Original Paper 27 May 2008 Pages: 1325 - 1335

   

9. MZ3 can induce G2/M-phase arrest and apoptosis in human leukemia cells

   • Liang Fang
   • Li Shen
   • Bo Yang

   Original Paper 20 May 2008 Pages: 1337 - 1345

   

10. Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment

    • Ke-da Yu
    • Gen-hong Di
    • Zhio-Ming Shao

    Original Paper 17 May 2008 Pages: 1347 - 1354

    

11. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma

    • Wei Li
    • Wei Wang
    • Ding Ma

    Original Paper 14 May 2008 Pages: 1355 - 1361

    

12. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma

    • Yasuo Awakura
    • Eijiro Nakamura
    • Osamu Ogawa

    Original Paper 16 May 2008 Pages: 1363 - 1369

    

13. A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer

    • Hidefumi Sasaki
    • Katsuhiro Okuda
    • Yoshitaka Fujii

    Original Paper 14 May 2008 Pages: 1371 - 1376

    

14. Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors

    • Seung Up Kim
    • Do Young Kim
    • Kwang-Hyub Han

    Original Paper 16 May 2008 Pages: 1377 - 1384

    

15. Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study

    • Yoichi Arai
    • Hideyuki Akaza
    • Yasuo Ohashi

    Original Paper 20 May 2008 Pages: 1385 - 1396

    

16. Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects

    • Christoph Mundhenke
    • Marion Tina Weigel
    • Nicolai Maass

    Original Paper 09 May 2008 Pages: 1397 - 1405